Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo
Hao Yin, Chun‐Qing Song, J. Robert Dorkin, et al.
Nature Biotechnology (2016) Vol. 34, Iss. 3, pp. 328-333
Open Access | Times Cited: 816

Showing 1-25 of 816 citing articles:

Lipid nanoparticles for mRNA delivery
Xucheng Hou, Tal Zaks, Róbert Langer, et al.
Nature Reviews Materials (2021) Vol. 6, Iss. 12, pp. 1078-1094
Open Access | Times Cited: 2249
Adeno-associated virus vector as a platform for gene therapy delivery
Dan Wang, Phillip W.L. Tai, Guangping Gao
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 5, pp. 358-378
Open Access | Times Cited: 1838
Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR–Cas gene editing
Qiang Cheng, Tuo Wei, Lukas Farbiak, et al.
Nature Nanotechnology (2020) Vol. 15, Iss. 4, pp. 313-320
Open Access | Times Cited: 1504
Delivering CRISPR: a review of the challenges and approaches
Christopher A. Lino, Jason C. Harper, James P. Carney, et al.
Drug Delivery (2018) Vol. 25, Iss. 1, pp. 1234-1257
Open Access | Times Cited: 995
Overcoming cellular barriers for RNA therapeutics
Steven F. Dowdy
Nature Biotechnology (2017) Vol. 35, Iss. 3, pp. 222-229
Closed Access | Times Cited: 970
CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes
Alexis C. Komor, Ahmed H. Badran, David R. Liu
Cell (2016) Vol. 168, Iss. 1-2, pp. 20-36
Open Access | Times Cited: 931
Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery
Piotr S. Kowalski, Arnab Rudra, Lei Miao, et al.
Molecular Therapy (2019) Vol. 27, Iss. 4, pp. 710-728
Open Access | Times Cited: 903
Drug delivery systems for RNA therapeutics
Kalina Paunovska, David Loughrey, James E. Dahlman
Nature Reviews Genetics (2022) Vol. 23, Iss. 5, pp. 265-280
Open Access | Times Cited: 832
Identification of preexisting adaptive immunity to Cas9 proteins in humans
Carsten T. Charlesworth, Priyanka S. Deshpande, Daniel P. Dever, et al.
Nature Medicine (2019) Vol. 25, Iss. 2, pp. 249-254
Open Access | Times Cited: 794
Advances in Biomaterials for Drug Delivery
Owen S. Fenton, Katy N. Olafson, Padmini S. Pillai, et al.
Advanced Materials (2018) Vol. 30, Iss. 29
Open Access | Times Cited: 739
Targeted drug delivery strategies for precision medicines
Mandana T. Manzari, Yosi Shamay, Hiroto Kiguchi, et al.
Nature Reviews Materials (2021) Vol. 6, Iss. 4, pp. 351-370
Open Access | Times Cited: 733
Emerging Issues in AAV-Mediated In Vivo Gene Therapy
Pasqualina Colella, Giuseppe Ronzitti, Federico Mingozzi
Molecular Therapy — Methods & Clinical Development (2017) Vol. 8, pp. 87-104
Open Access | Times Cited: 729
A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing
Jonathan D. Finn, Amy Smith, Mihir Patel, et al.
Cell Reports (2018) Vol. 22, Iss. 9, pp. 2227-2235
Open Access | Times Cited: 686
Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repair
Kunwoo Lee, Michael J. Conboy, Hyo Min Park, et al.
Nature Biomedical Engineering (2017) Vol. 1, Iss. 11, pp. 889-901
Open Access | Times Cited: 667
Tools for translation: non-viral materials for therapeutic mRNA delivery
Khalid A. Hajj, Kathryn A. Whitehead
Nature Reviews Materials (2017) Vol. 2, Iss. 10
Open Access | Times Cited: 654
Engineered biomaterials for in situ tissue regeneration
Akhilesh K. Gaharwar, Irtisha Singh, Ali Khademhosseini
Nature Reviews Materials (2020) Vol. 5, Iss. 9, pp. 686-705
Closed Access | Times Cited: 648
Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells
Benjamin P. Kleinstiver, Shengdar Q. Tsai, Michelle S. Prew, et al.
Nature Biotechnology (2016) Vol. 34, Iss. 8, pp. 869-874
Open Access | Times Cited: 646
Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy
Matthias A. Oberli, Andreas M. Reichmuth, J. Robert Dorkin, et al.
Nano Letters (2016) Vol. 17, Iss. 3, pp. 1326-1335
Open Access | Times Cited: 610
Advances in the delivery of RNA therapeutics: from concept to clinical reality
James C. Kaczmarek, Piotr S. Kowalski, Daniel G. Anderson
Genome Medicine (2017) Vol. 9, Iss. 1
Open Access | Times Cited: 580
A multifunctional AAV–CRISPR–Cas9 and its host response
Wei Leong Chew, Mohammadsharif Tabebordbar, Jason Cheng, et al.
Nature Methods (2016) Vol. 13, Iss. 10, pp. 868-874
Open Access | Times Cited: 567
Delivery technologies for genome editing
Hao Yin, Kevin Kauffman, Daniel G. Anderson
Nature Reviews Drug Discovery (2017) Vol. 16, Iss. 6, pp. 387-399
Closed Access | Times Cited: 520
Exosome–Liposome Hybrid Nanoparticles Deliver CRISPR/Cas9 System in MSCs
Yao Lin, Jiahua Wu, Weihuai Gu, et al.
Advanced Science (2018) Vol. 5, Iss. 4
Open Access | Times Cited: 506
Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications
Chang Liu, Li Zhang, Hao Liu, et al.
Journal of Controlled Release (2017) Vol. 266, pp. 17-26
Open Access | Times Cited: 495
CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery
Hongxia Wang, Mingqiang Li, Ciaran M. Lee, et al.
Chemical Reviews (2017) Vol. 117, Iss. 15, pp. 9874-9906
Closed Access | Times Cited: 489
Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents
Xue Gao, Yong Tao, Verónica Lamas, et al.
Nature (2017) Vol. 553, Iss. 7687, pp. 217-221
Open Access | Times Cited: 478
Page 1 - Next Page

Scroll to top